11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...

10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)

10/31/2022Financial-related Company News Digest (October 2022)

10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab

10/28/2022Recent Executive Moves

10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations

10/27/2022Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...

10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...

10/25/2022Crisis or Opportunity? Biotech Companies Are at A Crossroads in The St...

10/24/2022NASDAQ-listed BIMI Disposes Acquired Chinese Pharma Distributor

10/21/2022Recent Executive Moves

10/20/2022IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025

10/19/2022Fitch: US Biomanufacturing Plan Poses Minor Risks to Chinese Pharma CD...

10/19/2022GSK to Focus on Innovative Medicines and Vaccines to Drive Growth in C...

10/19/2022Viva Biotech Buys Hong Kong CRO SYNthesis to Boost Preclinical Offerin...

10/19/2022The Emergence of Commercial Health Insurances as An Access Route to th...

10/18/2022China's Party Congress Promises Continuity, Not Change (AP)

10/18/2022Xi's Work Report to the 20th Party Congress: 5 Takeaways (The Diplomat...

10/18/2022Financing for China Drugmakers Hits the Lowest of the Year (PharmaDJ)

10/18/2022Report of the CPC 20th Congress: Key Messages Related to Healthcare

10/17/2022NHSA Announces Conclusion of Expert Evaluation for DRDL Inclusion and ...

10/16/2022SMEI: Chinese Terminal Drug Market Growth Slowed to 1.7% in H1/2022

10/14/2022Singapore Is Becoming a Hotspot for Chinese Drugmakers Looking to Go P...

10/14/2022Recent Executive Moves

10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)

10/11/2022Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGen...

10/11/2022HanAll's Licensed Partner in China Enters Sublicense Deal with CSPC to...

10/10/2022Genentech and Jemincare Enter $650M Biobucks Pact for Latter's Prosta...

10/9/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Proto...

10/8/2022U.S. Adds 31 Additional Chinese Cos to Unverified List, But Removing A...

Page:63/361 Total number of articles:10807: [First][<<] [61] [62] [63] [64] [65] [>>] [End]